EU Pharma Wants Regulators’ Help To Simplify Digital Endpoints Landscape

The European pharmaceutical industry federation, EFPIA, says its member companies are not looking for shortcuts to develop and validate digital biomarkers, but want help from regulators to create the right evidence.

Smart watch for healthcare technology with futuristic element
Digital Endpoints May Allow A More Authentic Assessment Of A Patient’s Experience In A Clinical Trial • Source: Shutterstock

More from Europe

More from Geography